greeksoup/ stock research

Health Catalyst, Inc. SEC filings

Health Catalyst filed 25 documents with the SEC in the last twelve months, the latest report being the 10-Q of 6 August 2026. The latest filing, on 14 September 2026, was an S-8: s-8.

Filings in twelve months2515 of them 8-K news
Latest report10-Qfiled 6 Aug 2026
Latest filingS-814 Sep 2026
Last results, two-day move-27.6%results filed 6 Aug 2026
New to this? How to read this page
  1. Companies file with the SEC when something happens. 10-Q and 10-K are the quarterly and annual reports; 8-K is news that cannot wait for the next report.
  2. An 8-K says which items it covers, such as results, a change at the top or a big contract. A foreign company files a 6-K instead.
  3. The results release is usually an 8-K filed the day results come out, before the 10-Q or 10-K.
  4. Every filing links to the original on EDGAR, the SEC's own site.

Twelve months of filings

by kind

Most of the filings were other company news (10). Results came out 5 times.

Each mark is one filing on the day it was filed, in rows by kind. Hover or tap a mark for the form and what it was about.

The share price around each results release

close before to close after

Over the last 5 releases the share price moved 13.4% on average in the two days around results, the most on 12 Mar 2026 (-29.0%).

12 Jan 2026-2.8%$2.47 to $2.40
12 Mar 2026-29.0%$1.86 to $1.32
11 May 2026-2.6%$1.52 to $1.48
6 Aug 2026-27.6%$2.39 to $1.73
Daily closeResults filed

Each ring marks a results filing. The move runs from the last close before the filing to the first close after it, so it covers results released before the open or after the close. Hover the line for any day's close.

What the company told investors on 8-K

15 filings

Health Catalyst's 15 news filings (8-K) were mostly about officer or director change (8) and regulation FD disclosure (7).

  • Officer or director changeSomeone joined, left or changed role at the top
    8 · latest 14 Sep 2026
  • Regulation FD disclosureMaterial shared with investors, often slides or a presentation
    7 · latest 14 Sep 2026
  • Results of operationsThe quarterly results release
    5 · latest 6 Aug 2026
  • Material agreementA large contract or deal was signed
    2 · latest 4 Jun 2026
  • Termination of a material agreementA large contract ended
    1 · latest 6 Aug 2026
  • Acquisition or disposition completedA purchase or sale of a business closed
    1 · latest 6 Aug 2026
  • Shareholder voteResults of a vote at a shareholder meeting
    1 · latest 20 Jul 2026
  • Other eventsNews the company chose to file
    1 · latest 27 Apr 2026

Each line is one kind of news, with what it means in plain words. Each square is one filing; a filing can carry more than one kind, so the squares can add up to more than the filings. The date opens the latest one on EDGAR.

How it compares

every company on the site

    The bar ranks every company on the site from the lowest on the left to the highest on the right, in three equal thirds; the small figures under it are the values where each third starts, and the black tick is the middle company. The orange dot is this company; the grey ticks are the other companies in its industry (hover or tap for names). A hatched block is companies tied at none.

    Every filing as a table

    In the last twelve months Health Catalyst, Inc. filed 25 documents with the SEC of the kinds listed here: 15 current reports (8-K), about 8 officer or director change; 7 regulation FD disclosure; 5 results of operations; 2 material agreement; 1 termination of a material agreement; 3 quarterly reports (10-Q), 2 employee share plan registrations (S-8), 1 additional proxy material (DEFA14A), 1 proxy statement (DEF 14A), 1 preliminary proxy (PRE 14A), 1 amended annual report (10-K/A). The latest, filed 14 September 2026: S-8, employee share plan registration. The 10-K, the 10-Qs and the proxy statement themselves, each with a link to open it, are on the documents page.

    FiledFormWhat it was aboutPeriod or event dateFiling
    14 September 2026S-8employee share plan registrationEDGAR
    14 September 20268-KOfficer or director change, Regulation FD disclosure11 September 2026EDGAR
    8 September 20268-KOfficer or director change, Regulation FD disclosure4 September 2026EDGAR
    6 August 202610-Qquarterly report30 June 2026EDGAR
    6 August 20268-KTermination of a material agreement, Acquisition or disposition completed, Results of operations, Regulation FD disclosure31 July 2026EDGAR
    20 July 20268-KShareholder vote16 July 2026EDGAR
    4 June 20268-KMaterial agreement, Regulation FD disclosure4 June 2026EDGAR
    3 June 2026DEFA14Aadditional proxy materialEDGAR
    3 June 2026DEF 14Aproxy statement31 December 2025EDGAR
    19 May 2026PRE 14Apreliminary proxy31 December 2025EDGAR
    11 May 202610-Qquarterly report31 March 2026EDGAR
    11 May 20268-KResults of operations11 May 2026EDGAR
    30 April 202610-K/Aamended annual report31 December 2025EDGAR
    30 April 20268-KOfficer or director change, Regulation FD disclosure29 April 2026EDGAR
    27 April 20268-KOfficer or director change, Other events24 April 2026EDGAR
    3 April 20268-KOfficer or director change31 March 2026EDGAR
    12 March 2026S-8employee share plan registrationEDGAR
    12 March 202610-Kannual report31 December 2025EDGAR
    12 March 20268-KResults of operations12 March 2026EDGAR
    18 February 20268-KOfficer or director change, Regulation FD disclosure12 February 2026EDGAR
    23 January 20268-KOfficer or director change20 January 2026EDGAR
    12 January 20268-KResults of operations12 January 2026EDGAR
    2 December 20258-KMaterial agreement, Officer or director change, Regulation FD disclosure1 December 2025EDGAR
    10 November 202510-Qquarterly report30 September 2025EDGAR
    10 November 20258-KResults of operations10 November 2025EDGAR
    An 8-K is what a company files within four business days of a material event; the SEC numbers the events, and the words here are the SEC's own headings, shortened.
    Read moreForm 4, Form 144, 13F and Schedule 13D and 13G have their own pages. Prospectus supplements and correspondence are not listed.